TATA Health International Holdings Limited (HKG:1255)
Hong Kong · Delayed Price · Currency is HKD 2.000
0.00 (0.00%)
Sep 29, 2026, 3:23 PM HKT
HKG:1255 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 97.55 | 99.8 | 129.68 | 207.54 | 144.61 | 160.93 | |
Revenue Growth | -1.95% | -23.04% | -37.52% | 43.52% | -10.14% | 3.58% |
Cost of Revenue | 28.56 | 19.54 | 39.51 | 56.78 | 30.66 | 56.21 |
Gross Profit | 68.99 | 80.26 | 90.17 | 150.76 | 113.94 | 104.72 |
Selling, General & Admin | 94.93 | 103.12 | 125.08 | 180.97 | 145.63 | 162.92 |
Operating Expenses | 95.28 | 103.46 | 124.13 | 182.3 | 145.61 | 162.92 |
Operating Income | -26.28 | -23.19 | -33.96 | -31.54 | -31.67 | -58.2 |
Interest Expense | -1.98 | -2.77 | -4.21 | -1.66 | -2.49 | -2.76 |
Interest & Investment Income | 0.29 | 0.29 | 2.92 | 2.45 | 1.45 | 1.19 |
Earnings From Equity Investments | - | - | - | -0.21 | -0.4 | -0.57 |
Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.01 | -0.03 | -0.01 | -0.47 |
Other Non Operating Income (Expenses) | 2.92 | 3.85 | 0.5 | 2 | 3.8 | -4.22 |
EBT Excluding Unusual Items | -25.04 | -21.81 | -34.73 | -28.99 | -29.33 | -65.04 |
Gain (Loss) on Sale of Investments | - | - | - | 0.21 | - | -1.51 |
Gain (Loss) on Sale of Assets | 21.63 | 40.1 | -5.55 | -0.08 | 32.96 | 0.35 |
Asset Writedown | -4.31 | -4.31 | -12.02 | -7.02 | -0.6 | -2.66 |
Other Unusual Items | - | - | -15.72 | 0.46 | -0.53 | -0.29 |
Pretax Income | -7.72 | 13.99 | -68.03 | -35.42 | 2.5 | -69.14 |
Income Tax Expense | 0.64 | 0.64 | 0.31 | 0.63 | 0.9 | 1.31 |
Earnings From Continuing Operations | -8.36 | 13.35 | -68.34 | -36.05 | 1.6 | -70.45 |
Minority Interest in Earnings | 0.82 | - | - | 3.75 | 6.45 | 9.69 |
Net Income | -7.54 | 13.35 | -68.34 | -32.29 | 8.05 | -60.76 |
Net Income to Common | -7.54 | 13.35 | -68.34 | -32.29 | 8.05 | -60.76 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 243 | 243 | 243 | 243 | 243 | 232 |
Shares Outstanding (Diluted) | 243 | 243 | 243 | 243 | 243 | 232 |
Shares Change | - | - | - | - | 4.67% | 8.42% |
EPS (Basic) | -0.03 | 0.05 | -0.28 | -0.13 | 0.03 | -0.26 |
EPS (Diluted) | -0.03 | 0.05 | -0.28 | -0.13 | 0.03 | -0.26 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -20.79 | -3.56 | 33.8 | 12.12 | -5.98 |
Free Cash Flow Per Share | - | -0.09 | -0.01 | 0.14 | 0.05 | -0.03 |
Gross Margin | 70.73% | 80.43% | 69.53% | 72.64% | 78.80% | 65.07% |
Operating Margin | -26.94% | -23.24% | -26.19% | -15.20% | -21.90% | -36.17% |
Profit Margin | -7.72% | 13.38% | -52.70% | -15.56% | 5.56% | -37.76% |
Free Cash Flow Margin | - | -20.84% | -2.74% | 16.28% | 8.38% | -3.71% |
EBITDA | -23.52 | -20.55 | -31.56 | -30.37 | -30.56 | -56.79 |
EBITDA Margin | -24.11% | -20.59% | -24.34% | -14.63% | -21.13% | -35.29% |
D&A For EBITDA | 2.77 | 2.64 | 2.4 | 1.17 | 1.11 | 1.41 |
EBIT | -26.28 | -23.19 | -33.96 | -31.54 | -31.67 | -58.2 |
EBIT Margin | -26.94% | -23.24% | -26.19% | -15.20% | -21.90% | -36.17% |
Effective Tax Rate | - | 4.55% | - | - | 35.96% | - |